Among the most popular fund investment industries, there are Internet, Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Chemclin, Genetron Health, UNIMED.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Zhongjin Kangrui Medical Industrial Fund, startups are often financed by Legend Star, WI Harper Group, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are V Star Capital, Shenshang Xingye Fund, Ping An Ventures. In the next rounds fund is usually obtained by Vivo Capital, Highlight Capital, Alexandria Venture Investments.
Deals in the range of more than 100 millions dollars are the general things for fund. Opposing the other organizations, this Zhongjin Kangrui Medical Industrial Fund works on 4 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2013. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
UNIMED | 23 Jan 2018 | Beijing | |||
Genetron Health | $61M | 04 Jan 2018 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
UNIMED | 23 Jan 2018 | Beijing | |||
Genetron Health | $61M | 04 Jan 2018 | Dongcheng District, Beijing, China |
